The Effect of Dapagliflozin on Platelet Function Testing Profiles in Diabetic Patients: The EDGE Pilot Study

INTRODUCTION: This prospective pharmacodynamic (PD) study assessed the effect of the sodium-glucose co-transporter-2 inhibitor (SGLT2i), dapagliflozin, on platelet reactivity. METHODS: Patients with stable coronary artery disease (CAD) and type 2 diabetes mellitus (T2DM) (n = 27) who were on mainten...

Descripción completa

Detalles Bibliográficos
Autores principales: Seecheran, Naveen, Grimaldos, Kathryn, Ali, Kabeer, Grimaldos, Gabriella, Richard, Srivane, Ishmael, Aleena, Gomes, Ceylon, Karan, Abhinav, Seecheran, Rajeev, Seecheran, Valmiki, Persad, Sangeeta, Abdullah, Harun, Peram, Lakshmipathi, Dookeeram, Darren, Giddings, Stanley, Motilal, Shastri, Raza, Sadi, Tello-Montoliu, Antonio, Schneider, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555038/
https://www.ncbi.nlm.nih.gov/pubmed/34643895
http://dx.doi.org/10.1007/s40119-021-00242-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555038/
https://www.ncbi.nlm.nih.gov/pubmed/34643895
http://dx.doi.org/10.1007/s40119-021-00242-6

Ejemplares similares